Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period)Previous forecast published 12 August 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The other areas of the nano/micro-technology-related business were slightly below forecast, while the macro-technology-related business exceeded forecast. Profit exceeded forecast due to lower outsourced processing costs and depreciation, raw material and other costs remaining within the expected range, and some research and development and other expenses being deferred to the second half.
| Item | Details |
|---|---|
| Net Sales | ¥635 million → ¥615 million（-3.1%） |
| Operating profit | ¥27 million → ¥48 million（+80.9%） |
| Ordinary income | ¥31 million → ¥51 million（+65.5%） |
| Profit attributable to owners of the parent | ¥19 million → ¥33 million（+68.2%） |
| Net income per share | ¥3.46 / sen → ¥5.83 / sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) |
| Publication date of previous forecast | 12 August 2026 |
| Previous-period results | Revenue ¥664 million, operating profit ¥113 million, ordinary profit ¥115 million, interim net profit ¥104 million, interim net profit per share ¥18.39 |
| Reason for the revision | The other areas of the nano/micro-technology-related business were slightly below forecast, while the macro-technology-related business exceeded forecast. Profit exceeded forecast due to lower outsourced processing costs and depreciation, raw material and other costs remaining within the expected range, and some research and development and other expenses being deferred to the second half. |
| Consolidated / non-consolidated | Non-consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue was slightly below forecast in the other areas of the nano/micro-technology-related business, while the macro-technology-related business exceeded forecast. Profit exceeded forecast due to lower outsourced processing costs, lower depreciation resulting from delays in part of the new capital investment plan, raw material and other costs remaining within the expected range, and some research and development and other expenses being deferred to the second half.